An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia
Clinical trial NCT06924255 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06924255
- Sponsor
- Collaborative Neuroscience Research, LLC
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2025-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.